Evidence map›Paper›PMID 41597355›Full record

SynthesisMedicina (Kaunas, Lithuania)2025

Heart Failure Outcomes with SGLT2 Inhibitors in Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Raghad Rasheed Alrasheed, Amenah Fayez Altaf, Abdullah Hameed Althurwi, Shahad Fahad Alrodan, Manal Hussain Asiri, Bushra Abdulrahman Alsaluli, Muath Awadh Alsurur, Khalid Ali Alghamdi, Ahmed Anwer Alrowaithi, Nariman Safar Almalki

Abstract readSystematic ReviewMeta-AnalysisReview
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raghad Rasheed AlrasheedFaculty of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh 11564, Saudi Arabia.
Amenah Fayez AltafFaculty of Medicine, Fakeeh College for Medical Sciences, Jeddah 23323, Saudi Arabia.ORCID 0009-0009-3059-8203
Abdullah Hameed AlthurwiFaculty of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.
Shahad Fahad AlrodanFaculty of Medicine, Fakeeh College for Medical Sciences, Jeddah 23323, Saudi Arabia.ORCID 0009-0000-4787-0239
Manal Hussain AsiriFaculty of Medicine, Batterjee Medical College, Jeddah 21442, Saudi Arabia.ORCID 0009-0005-3810-5048
Bushra Abdulrahman AlsaluliFaculty of Medicine, King Khalid University, Abha 62521, Saudi Arabia.
Muath Awadh AlsururFaculty of Medicine, Al Jouf University, Sakaka 72388, Saudi Arabia.
Khalid Ali AlghamdiFaculty of Medicine, Al Baha University, Al Baha 65431, Saudi Arabia.
Ahmed Anwer AlrowaithiFaculty of Medicine, King Abdulaziz University-Rabigh Branch, Rabigh 25732, Saudi Arabia.
Nariman Safar AlmalkiKing Abdullah Medical Complex, Second Health Cluster, Ministry of Health, Jeddah 23816, Saudi Arabia.ORCID 0009-0005-7951-3515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Heart FailureSodium-Glucose Transporter 2 InhibitorsHospitalizationHumansRandomized Controlled Trials as TopicSodium-Glucose Transporter 2 Inhibitorscardiovascular deathheart failuresodium-glucose transporter 2 inhibitorstype 2 diabetes mellitus

Identifiers

PMID41597355
PMCPMC12843294

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.